USA - NASDAQ:EPIX - CA29668H7085 - Common Stock
The current stock price of EPIX is 0.2112 USD. In the past month the price decreased by -89%. In the past year, price decreased by -96.73%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 21.01 | 393.01B | ||
AMGN | AMGEN INC | 13.09 | 153.65B | ||
GILD | GILEAD SCIENCES INC | 14.74 | 141.56B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 22.62 | 98.23B | ||
REGN | REGENERON PHARMACEUTICALS | 12.97 | 62.75B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.45B | ||
ARGX | ARGENX SE - ADR | 79.48 | 45.09B | ||
ONC | BEONE MEDICINES LTD-ADR | 5.84 | 39.75B | ||
INSM | INSMED INC | N/A | 30.60B | ||
NTRA | NATERA INC | N/A | 24.86B | ||
BNTX | BIONTECH SE-ADR | N/A | 23.13B | ||
BIIB | BIOGEN INC | 8.9 | 20.89B |
ESSA Pharma, Inc. is a clinical stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia and currently employs 35 full-time employees. The company went IPO on 2021-02-22. The firm is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.
ESSA PHARMA INC
999 West Broadway, Suite 720
Vancouver BRITISH COLUMBIA V5Z 1K5 CA
CEO: David Parkinson
Employees: 35
Phone: 17783310962
The current stock price of EPIX is 0.2112 USD. The price increased by 0.62% in the last trading session.
The exchange symbol of ESSA PHARMA INC is EPIX and it is listed on the Nasdaq exchange.
EPIX stock is listed on the Nasdaq exchange.
7 analysts have analysed EPIX and the average price target is 1.73 USD. This implies a price increase of 721.02% is expected in the next year compared to the current price of 0.2112. Check the ESSA PHARMA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ESSA PHARMA INC (EPIX) has a market capitalization of 9.99M USD. This makes EPIX a Nano Cap stock.
ESSA PHARMA INC (EPIX) currently has 35 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ESSA PHARMA INC (EPIX) has a dividend yield of 800.68%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of EPIX dividend history, reliability and sustainability.
ESSA PHARMA INC (EPIX) will report earnings on 2025-12-15, after the market close.
ESSA PHARMA INC (EPIX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.64).
The outstanding short interest for ESSA PHARMA INC (EPIX) is 8.2% of its float. Check the ownership tab for more information on the EPIX short interest.
ChartMill assigns a fundamental rating of 3 / 10 to EPIX. While EPIX has a great health rating, there are worries on its profitability.
Over the last trailing twelve months EPIX reported a non-GAAP Earnings per Share(EPS) of -0.64. The EPS decreased by -6.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -22.73% | ||
ROE | -23.07% | ||
Debt/Equity | 0 |
7 analysts have analysed EPIX and the average price target is 1.73 USD. This implies a price increase of 721.02% is expected in the next year compared to the current price of 0.2112.